Tandem Diabetes Care, an insulin delivery and diabetes technology company, announced it received FDA clearance for the Android version of its mobile app Tandem Mobi. The system, powered by Control-IQ ...
The t:slim X2™ Insulin Pump with Abbott’s FreeStyle Libre® 3 Plus Sensor is now available in the United States, beginning global commercial rollout. Tandem Diabetes Care begins global commercial ...
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump with Control-IQ+ ...
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced Health Canada authorization for distribution of the Tandem t:slim mobile ...
The U.S. Food & Drug Administration has issued an urgent medical device correction. Specifically, an error on the t:slim X2 insulin pump has been stopping insulin ...
The U.S. Food & Drug Administration has issued an urgent medical device correction. Specifically, an error on the t:slim X2 insulin pump has been stopping insulin ...
Tandem Diabetes has issued a voluntary correction for its t:slim X2 insulin pumps following confirmed adverse events due to a dangerous error. The error will ...
“The commercial availability of this new offering is a testament to our decade-long partnership with Dexcom and shared commitment to continued leadership in advancing AID systems,” said Mark Novara, ...
MARKHAM, Ontario--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by Health Canada, in-warranty t:slim X2™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback